Details for New Drug Application (NDA): 205215
✉ Email this page to a colleague
The generic ingredient in INDOMETHACIN is indomethacin sodium. There are fifteen drug master file entries for this compound. Additional details are available on the indomethacin sodium profile page.
Summary for 205215
Tradename: | INDOMETHACIN |
Applicant: | Jubilant Generics |
Ingredient: | indomethacin |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 205215
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 25MG | ||||
Approval Date: | Aug 25, 2017 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
Approval Date: | Aug 25, 2017 | TE: | RLD: | No |
Complete Access Available with Subscription